...
Progenics Pharmaceuticals Inc....
...
Progenics Pharmaceuticals Inc....
...
Progenics Pharmaceuticals Q2 net loss increases
Trading Markets (press release)
Progenics Pharmaceuticals, a biopharmaceutical company, has reported a net loss of $15....
...
Benzinga
Trade Like Hedge Fund Billionaire Paul Tudor Jones (EEM, FXI, MJN, PGNX, RSX, XLP)
Benzinga
Interestingly, according to Tudor Investment's 13-F, the firm holds a very large position in tiny biotech firm Progenics Pharmaceuticals (NASDAQ: PGNX ....
...
Progenics Pharmaceuticals Reports 2Q Financial Results
Trading Markets (press release)
Progenics Pharmaceuticals announced its results of operations for the second quarter and six months ended June 30....